Janus Contrarian Fund (JSVAX)

Investing Opportunistically in Non-Consensus Equity Ideas

SHARE CLASS

FUND FACTS (JSVAX)

Inception Date2/29/2000
NAV (As of 7/29/16)$17.85
Total Net Assets (As of 6/30/16)$2.67B
Annual Expense Ratio
(As of fiscal year end 9/30/15)
GROSS 1.04%
NET 1.04%

Performance (As of 6/30/16)
1 Year-14.98%
3 Year3.97%
5 Year6.58%
10 Year4.29%
Morningstar (As of 6/30/16)
CategoryMid-Cap Blend
Equity
Style Box

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold. For the most recent month-end performance click here.

Returns greater than one year are annualized.

Net expense ratios reflect the expense waiver, if any, Janus Capital has contractually agreed to through 2/1/17.

Data as of 6/30/16. Index represents the S&P 500® Index.

TOP HOLDINGS (% of Fund)

United Continental Holdings Inc 8.06
St Joe Co 6.94
Enterprise Products Partners LP 5.36
Knowles Corp 5.26
Mattel Inc 5.20
Ball Corp 4.62
Crown Holdings Inc 3.70
Air Products & Chemicals Inc 3.66
Motorola Solutions Inc 3.58
Zebra Technologies Corp 3.27
TOTAL49.65

CHARACTERISTICS

Number of Holdings
Equity Issues

46
Market Capitalization
Weighted Average
Median

$15.88B
$9.04B
Portfolio Turnover Ratio
(1-year trailing)

52.99%
Price/Earnings Ratio
(1-year forward)

16.86
Price/Book Ratio
(1-year forward)

2.75
Earnings Growth Rate
(1-year forward)

4.88%

MONTHLY TOP EQUITY
CONTRIBUTORS & DETRACTORS

CONTRIBUTORS
Enterprise Products Partners LP
Energizer Holdings Inc
Edgewell Personal Care Co
St Joe Co
Dollar Tree Inc
DETRACTORS
United Continental Holdings Inc
Synchrony Financial
E*TRADE Financial Corp
Knowles Corp
American Airlines Group Inc

SECTOR ALLOCATION (%)

FUND INDEX 
Consumer Discretionary 21.86 12.28
 
 
Financials 17.19 15.75
 
 
Materials 15.98 -
 
Information Technology 14.21 19.77
 
 
Industrials 12.23 10.19
 
 
Consumer Staples 7.65 10.56
 
 
Energy 7.30 7.40
 
 
Health Care 2.54 14.69
 
 
Cash & Equivalents 1.04 -
 

DEVELOPED VS. EMERGING MARKET EXPOSURE (%)

FUNDINDEX
U.S. 97.25 100.00
Non-U.S. Developed 1.71 -
Cash & Equivalents 1.04 -

REGIONS (%)

FUNDINDEX
North America 97.27 100.00
Europe 1.69 -
Cash & Equivalents 1.04 -

MARKET CAPITALIZATION RANGE OF EQUITY HOLDINGS (%)

FUNDINDEX
Over $100 Billion 1.30 45.29
$50 Billion to $100 Billion 8.25 16.42
$10 Billion to $50 Billion 38.66 33.91
$5 Billion to $10 Billion 17.97 3.97
$1 Billion to $5 Billion 29.55 0.41
$500 Million to $1 Billion 2.27 -
N/A 0.96 -

Equity country, regional, sector and industry weights based on MSCI and GICS classifications. Fixed income country, regional, sector and industry weights based on Barclays classifications.